Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer
{{output}}
Introduction: Several systemic therapies have demonstrated a survival advantage in metastatic castration resistant prostate cancer (mCRPC). Access to these medications varies significantly worldwide. In Australia until recently, ... ...
